Сцембликс | Novartis Russia

Novartis Russia

AMBER Tx General

Strategy Notes

Keyword match: +2 relevant, -0 negative signals.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-30 OPEN → INELIGIBLE · The programme page is a product information page for the drug Scemblix (asciminib) on Novartis Russia's website, not a funding or application opportunity. No application process exists.